Corrosions classified according to extent of body surface involved

ST19_CORROSIO_CLASSIFIED_ACCOR_EXTENT_BODY_SURFA_INVOLVED

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — T32 Cause of death: ICD-10 — T32 2 out of 7 registries used, show all original rules.	46
4. Check minimum number of events None	46
5. Include endpoints None	46
6. Filter based on genotype QC (FinnGen only)	44

Control definitions (FinnGen only)

Control exclude: CD2_BENIGN_FEMALE_GEN_OTH

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: T29|T3[0-2]
Name in latin: Corrosiones secundum summam superficiei corporis corrosam classificatae

NAME	ST19_CORROSIO_CLASSIFIED_ACCOR_EXTENT_BODY_SURFA_INVOLVED
CONTROL_EXCLUDE	CD2_BENIGN_FEMALE_GEN_OTH
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	T32
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	T32
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Corrosions classified according to extent of body surface involved based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	44	25	19
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	46.70	48.98	43.71

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

No data available

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

4.43

2.11

1.3

1.5

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2.64

1.80

1.4

2.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2.72

1.63

1.5

1.7

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2.76

1.52

1.4

2.7

13.56

15.43

nmol/l

—

(3023368) Bacteria identified in Blood by Culture

2.08

1.41

2.9

4.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.63

1.37

1.5

1.6

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.98

1.32

1.0

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

109

1.89

1.15

1.9

3.0

—

(3002179) Metamyelocytes/100 leukocytes in Blood

0.00

0.99

0.0

5.5

—

0.92

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2.22

0.93

3.0

5.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

364

2.16

0.91

14.0

14.2

34.89

21.26

mg/l

1.10

279

(3014576) Chloride [Moles/volume] in Serum or Plasma

2.00

0.85

4.0

5.8

101.17

104.66

mmol/l

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

274

1.72

0.84

5.2

4.0

15.20

14.74

pmol/l

0.48

256

(3025941) Bacteria identified in Stool by Culture

0.00

0.80

0.0

1.1

—

(36304419) Bacteria [Presence] in Urine

1.74

0.80

1.5

2.7

—

(40758558) Short blood count panel - Blood

1.74

0.80

5.2

7.3

—

(40761536) Microorganisms panel - Urine sediment

2.21

0.77

1.6

3.9

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.88

0.75

1.9

1.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2.12

0.75

1.6

2.0

—

(3037467) Urinalysis macro (dipstick) panel - Urine

237

1.61

0.74

4.7

4.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.74

0.70

1.3

1.6

—

(40768797) Stomach Pathology biopsy report

1.74

0.70

1.4

1.3

—

(3042936) Bacteria identified in Isolate by Culture

1.69

0.68

2.3

2.6

—

(3021601) Nitrite [Presence] in Urine by Test strip

162

1.55

0.67

5.6

5.5

0.00

estimate

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

336

1.75

0.66

5.1

4.6

1.84

1.83

mu/l

0.01

311

(3008898) HLA-B27 [Presence]

0.00

0.61

0.0

1.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.82

0.60

7.0

5.5

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

156

1.50

0.59

5.1

7.1

1.21

1.23

mmol/l

0.29

136

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1.69

0.44

2.2

2.4

4.88

4.69

pmol/l

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

348

1.53

0.44

4.3

4.2

5.88

5.74

mmol/l

0.31

320

(3022217) INR in Platelet poor plasma by Coagulation assay

155

1.38

0.42

9.6

7.9

0.98

1.15

inr

—

(3013707) Erythrocyte sedimentation rate by Westergren method

265

1.38

0.40

2.6

4.6

9.04

10.27

mm/h

0.27

249

(40761511) CBC panel - Blood by Automated count

382

1.67

0.39

17.6

12.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

128

1.38

0.39

4.9

4.1

—

(3019225) pH of Specimen

1.49

0.37

3.0

5.4

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

148

1.36

0.37

4.2

5.6

1.20

1.22

mmol/l

0.60

137

(3003694) ABO and Rh group [Type] in Blood

0.66

0.35

1.9

1.3

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

343

1.40

0.32

8.5

13.6

90.27

84.14

ml/min/173m2

0.96

280

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

134

1.30

0.28

1.5

1.9

95.29

100.90

pmol/l

—

(3029937) Albumin [Presence] in Urine by Test strip

1.35

0.27

4.5

3.8

0.00

estimate

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1.39

0.24

1.4

1.6

—

(40768804) Tissue Pathology biopsy report

154

0.78

0.24

1.6

1.9

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

156

1.25

0.23

1.8

2.8

—

(3009261) Glucose [Presence] in Urine by Test strip

166

1.25

0.23

4.4

3.9

0.00

estimate

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.21

0.0

3.5

—

15.05

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

0.00

0.21

0.0

1.5

—

(40760888) Immunoglobulin light chains.free panel - Serum

0.00

0.21

0.0

4.8

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.21

0.0

4.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

11.06

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.21

0.0

1.4

—

169.70

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

0.00

0.21

0.0

1.5

—

(3049717) Cytology report of Urine Cyto stain

0.00

0.21

0.0

1.5

—

(3037121) Protein [Mass/volume] in Urine

0.00

0.21

0.0

2.7

—

0.29

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

0.00

0.21

0.0

2.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

0.00

0.21

0.0

4.5

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

0.00

0.21

0.0

1.7

—

227.60

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

0.00

0.21

0.0

1.3

—

102.38

—

(3026008) Bacteria identified in Urine by Culture

1.26

0.18

4.4

3.5

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1.21

0.18

5.1

3.5

—

(3019150) Specific gravity of Urine by Refractometry

0.77

0.17

6.8

4.4

—

1.02

—

(3026493) Urate [Moles/volume] in Serum or Plasma

0.82

0.15

2.4

3.1

343.00

349.01

umol/l

—

(3013512) EKG study

104

1.21

0.14

3.0

3.8

—

(3035350) Ketones [Presence] in Urine by Test strip

164

1.16

0.12

4.5

3.8

0.00

estimate

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.18

0.10

1.8

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.05

0.09

1.8

2.0

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1.12

0.08

2.0

2.8

—

(3044889) 12 lead EKG panel

237

1.12

0.08

3.7

3.3

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

349

1.14

0.07

3.6

1.35

1.32

mmol/l

0.08

317

(1761868) Lipid panel - Serum or Plasma

139

1.12

0.06

3.2

2.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

100

1.13

0.06

3.5

3.7

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

333

1.08

0.02

3.9

4.8

38.41

38.75

mmol/mol

0.14

313

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

253

1.06

0.01

3.2

3.4

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

366

0.92

0.01

4.0

4.1

4.79

4.70

mmol/l

0.19

338

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

366

0.92

0.01

4.0

1.37

1.46

mmol/l

0.60

338

(3044640) Blood type and Crossmatch panel - Blood

109

1.01

0.00

1.9

2.6

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

266

1.04

0.00

5.4

3.3

59.14

44.57

u/l

0.33

258

(3017143) Hepatitis C virus Ab [Presence] in Serum

0.94

0.00

1.2

1.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

0.89

0.00

1.4

1.8

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

-0.00

0.0

3.0

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

0.00

-0.00

0.0

2.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

-0.00

0.0

4.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

0.00

-0.00

0.0

1.3

—

(3044290) Cell count panel - Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

0.00

-0.00

0.0

1.0

—

0.99

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

3.0

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

0.00

-0.00

0.0

1.0

—

5.88

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

3.0

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

0.00

-0.00

0.0

1.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

2.7

—

0.00

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

3.0

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.2

—

29.08

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

0.00

-0.00

0.0

1.8

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

0.94

-0.00

1.3

1.5

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

3.0

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

1509.40

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

0.00

-0.00

0.0

1.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

-0.00

0.0

2.7

—

110.00

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

0.00

-0.00

0.0

1.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

-0.00

0.0

1.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

2.5

—

11.17

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

5.6

—

145.71

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

-0.00

0.0

2.7

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

2.11

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

6.6

—

0.62

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

2.7

—

0.00

—

(21494434) Karyotype in Bone marrow

0.00

-0.00

0.0

1.0

—

(1616796) Gas panel - Central venous blood

0.00

-0.00

0.0

2.7

—

(40768795) Lymph node Pathology biopsy report

0.00

-0.00

0.0

1.6

—

(40760892) CBC W Ordered Manual Differential panel - Blood

160

1.00

-0.00

5.3

7.2

—

(3038515) Glucose [Moles/volume] in Venous blood

0.00

-0.00

0.0

3.4

—

6.75

—

(3023410) Appearance of Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

(3023420) DNA double strand Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

3.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(3044927) Protein electrophoresis panel - Urine

0.00

-0.00

0.0

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

0.90

-0.00

1.4

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

0.00

-0.00

0.0

2.3

—

(3052851) Hemolysis interference index of Serum or Plasma

0.00

-0.00

0.0

2.7

—

(40765096) Chromosome analysis panel by Banding

0.00

-0.00

0.0

1.6

—

(3000093) Morphology [Interpretation] in Blood Narrative

0.00

-0.00

0.0

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

3.0

—

(3008037) Lactate [Moles/volume] in Venous blood

0.00

-0.00

0.0

3.4

—

1.27

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

-0.00

0.0

2.7

—

4.04

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.02

-0.00

1.2

1.6

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

3.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

0.00

-0.00

0.0

1.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

2.5

—

38.95

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

388

1.03

-0.00

16.3

15.8

74.08

76.63

umol/l

0.38

388

(3037756) Immunofixation for Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.00

-0.00

0.0

1.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

0.00

-0.00

0.0

1.2

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ST19_CORROSIO_CLASSIFIED_ACCOR_EXTENT_BODY_SURFA_INVOLVED – Corrosions classified according to extent of body surface involved

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Corrosions classified according to extent of body surface involved

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Corrosions classified according to extent of body surface involved (ST19_CORROSIO_CLASSIFIED_ACCOR_EXTENT_BODY_SURFA_INVOLVED)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

LabWAS

Mortality – FinRegistry

Relationships between endpoints